Status:
UNKNOWN
HFNO Versus Nasal CPAP in Obese Patients Undergoing Deep Sedation for ERCP
Lead Sponsor:
Assiut University
Conditions:
Obese
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Endoscopic retrograde cholangio-pancreatography (ERCP) is commonly performed under deep sedation to provide amnesia, comfort, and optimal procedural conditions. However, anesthetic drugs commonly used...
Detailed Description
The incidence of hypoxia during ERCP with sedation has been reported to range from 16.2 to 39.2% (4) may be because ERCP procedures can be lengthy and are often performed in the prone position.(5) Hyp...
Eligibility Criteria
Inclusion
- patients undergoing elective ERCP with deep sedation will be enrolled
- age 18 - 70 years old
- obesity (BMI 30-35 kg/m2)
- American Society of Anaesthesiologists' physical status classification of 1 to 3
- Anticipated duration of the procedure is \> 15 minutes.
Exclusion
- • BMI \>35 kg/m2
- Simple procedures of \< 15 minutes duration.
- untreated or unstable cardiac conditions
- Nasal or oral disease resulting in difficulty of either nasal breathing or mouth breathing.
- Acute or chronic respiratory disorders as asthma and chronic obstructive pulmonary disease.
- Pregnant patients and patients having procedures with planned endotracheal intubation
- Expected difficult intubation patients.
Key Trial Info
Start Date :
October 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04912102
Start Date
October 30 2021
End Date
December 31 2025
Last Update
June 3 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.